Association of MLL2 mutation positive non-small cell lung cancer with prognosis.

被引：2
|
作者：
Ardeshir-Larijani, Fatemeh
Wildey, Gary
Fu, Pingfu
Bhateja, Priyanka
Lipka, Mary Beth
Dowlati, Afshin
机构：
[1] Case Western Reserve Univ, Univ Hosp Cleveland Med Ctr, Cleveland, OH USA
[2] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH USA
[3] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH USA
[4] Case Western Reserve Univ, Univ Hosp Seidman Canc Ctr, Case Comprehens Canc Ctr, Cleveland, OH USA
[5] Case Western Reserve Univ, Univ Hosp Seidman Canc Ctr, Case Comprehens Canc Ctr, Cleveland, OH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.11598
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11598
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Association of low RKIP expression with poor prognosis in non-small cell lung cancer.
    Meng, Lingbin
    Ji, Rui
    Laber, Damian A.
    Yan, Xuebo
    Xu, Xiaochun
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [32] The association between SLFN5 expression and the prognosis of non-small cell lung cancer
    Yang, Xiulin
    Peng, Rui
    Peng, Hong
    Zhang, Qian
    Long, Guangwen
    Wu, Guangjie
    Liang, Zongan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (01): : 682 - 689
  • [33] ASSOCIATION OF SEQUENCE VARIATIONS IN MICRORNAS WITH PROGNOSIS OF NON-SMALL CELL LUNG CANCER IN KOREAN PATIENTS
    Yoon, Kyong-Ah
    Han, Jihye
    Yoon, Hyekyoung
    Park, Sohee
    Lee, Geon Kook
    Lee, Hyun-Sung
    Zo, Jae Ill
    Lee, Jin Soo
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S297 - S298
  • [34] Rybrevant® Positive opinion in non-small cell lung cancer
    Robert, Typhaine
    ACTUALITES PHARMACEUTIQUES, 2022, 61 (612): : 9 - 9
  • [35] Association of pharmacokinetics and pharmacogenomics with safety and efficacy of gefitinib in patients with EGFR mutation positive advanced non-small cell lung cancer
    Hirose, Takashi
    Fujita, Ken-ichi
    Kusumoto, Sojiro
    Oki, Yasunari
    Murata, Yasunori
    Sugiyama, Tomohide
    Ishida, Hiroo
    Shirai, Takao
    Nakashima, Masanao
    Yamaoka, Toshimitsu
    Okuda, Kentaro
    Ohmori, Tohru
    Sasaki, Yasutsuna
    LUNG CANCER, 2016, 93 : 69 - 76
  • [36] Impact of early progression on prognosis for non-small cell lung cancer patients with EGFR mutation.
    Yoshitsugu, Kanako
    Kenmotsu, Hirotsugu
    Omae, Katsuhiro
    Omori, Shota
    Nakashima, Kazuhisa
    Wakuda, Kazushige
    Ono, Akira
    Naito, Tateaki
    Murakami, Haruyasu
    Takahashi, Toshiaki
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [37] Impact of Type 2 Diabetes Mellitus on the Prognosis of Non-Small Cell Lung Cancer
    Lu, You
    Hu, Yaohua
    Zhao, Yi
    Xie, Shuanshuan
    Wang, Changhui
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (01)
  • [38] PROGNOSIS OF SKIP N2 NON-SMALL CELL LUNG CANCER (NSCLC)
    Chang, Y.
    Cho, D.
    Choi, S.
    CHEST, 2020, 157 (06) : 23A - 23A
  • [39] Prognosis of stage I non-small cell lung cancer patients with positive pleural lavage cytology
    Tojo, T
    Takahama, M
    Kimura, M
    Kawaguchi, T
    Taniguchi, S
    Yamamoto, R
    Tada, H
    LUNG CANCER, 2005, 49 : S107 - S107
  • [40] Prognosis of stage I non-small cell lung cancer patients with positive pleural lavage cytology
    Yamamoto, R
    Tojo, T
    Nakajima, R
    Ideguchi, K
    Tada, H
    CHEST, 2004, 126 (04) : 912S - 913S
12345